Compugen CGEN
NASDAQ CGEN
$2.59 +0.03 (+1.17%)
As of: Sep 4, 2026 · 3:10 PM EDT

Compugen (CGEN) EBITDA Margin Growth (5y) (2014 - 2018)

Analysis

Compugen (CGEN) EBITDA Margin Growth (5y) (2014 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn -
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
10 Compugen 241.50 Mn 155.89 Mn -92,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 23,414.00
Mar 31, 2018 244,806.00
Dec 31, 2015 120,178.00
Jun 30, 2015 -301,664.00
Mar 31, 2015 94,204.00
Dec 31, 2014 778,698.00
Sep 30, 2014 -237,568.00